kadcyla - ado - trastuzumab emtansine injection, powder, lyophilized, for solution
(Ado-Trastuzumab Emtansine)Genentech, Inc.
Usage: Kadcyla treats HER2-positive metastatic breast cancer in adults who previously received trastuzumab and a taxane, and is used adjuvantly in HER2-positive early breast cancer patients with residual invasive disease after neoadjuvant taxane and trastuzumab-based treatment.